# SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada

> **NCT00323687** · PHASE4 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 50 (estimated)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** Truvada

## Key facts

- **NCT ID:** NCT00323687
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-10
- **Final completion:** 2007-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2008-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00323687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00323687, "SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00323687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*